NY-EDELMAN
25.7.2022 13:07:11 CEST | Business Wire | Press release
Edelman today announced the global launch of Edelman Smithfield, a financial communications boutique that specializes in the financial markets and strategic situations, serving clients in the United States, EMEA, Asia and beyond. The global launch brings together under one brand Edelman’s Financial Communications and Financial Services teams, combining specialized industry knowledge with global scale and localized expertise, while remaining connected to and integrated with Edelman’s full capabilities. Lex Suvanto will serve as Edelman Smithfield Global CEO.
Edelman Smithfield is focused on advising senior leaders and management teams navigating complex matters that impact reputation and valuation. The firm has deep expertise serving and communicating to the financial markets and is comprised of two primary practice areas:
- Partnering with companies in the financial markets to help them protect, promote and evolve their reputation. Edelman Smithfield is a leading communications advisor in the financial markets, working with investment firms, private equity and venture capital funds, hedge funds, banks, insurers, fintech, crypto and other financial markets participants to develop and execute tailored communications programs that build trust and strengthen reputations in the marketplace.
- Partnering with companies navigating and communicating with the financial markets and during strategic situations. Edelman Smithfield advises boards of directors, management teams and communications professionals on high impact strategic situations, such as mergers, acquisitions, IPOs, bankruptcies and restructurings, shareholder activism, litigation, management changes and regulatory matters, as well as ongoing engagement with the investment community, including investor relations and critical ESG matters.
Richard Edelman, CEO of Edelman, said, “The financial communications team has built an incredible platform and has advised on some of the highest profile clients and situations over the past several years. We continue to see significant demand from both existing and new clients for the work that they are leading, especially given the volatility and complexity of the global financial markets. There’s tremendous opportunity ahead, and we will continue to invest in Edelman Smithfield to ensure the team is well placed to define the next generation of financial communications.”
Edelman Smithfield is already a leading player in the financial communications industry. The firm’s asset management clients professionally manage more than $20 trillion combined, which, when coupled with insights from the annual Investor Trust survey, translates into a unique understanding of the global institutional investor landscape; Edelman Smithfield has advised on hundreds of transactions in the last five years, including some of the most prominent mergers and acquisitions, IPOs and restructurings.
Lex Suvanto, Global CEO of Edelman Smithfield, said, “We have a singular goal of building a financial communications powerhouse globally, and Edelman is providing the investment and runway to make this a reality. We are the only firm that specializes in the financial markets and strategic situations while bringing the reach and resources of broader Edelman. Together as a global team and with a unified banner and strategy, we will unlock new opportunities, while always prioritizing excellent client work, conducting ourselves with integrity and attracting and empowering an incredible team of dedicated advisors.”
Edelman Smithfield brings a strong leadership team with an impeccable track record of helping clients navigate the complex and dynamic financial markets. Global and regional leadership appointments include:
- Lex Suvanto, Global CEO
- John Kiely, Chairman of EMEA
- Andrew Wilde, Global Head of Financial Services
- Josh Hochberg, Global Chief Operating Officer
- Katie Spring, President, United States
- Alex Simmons, Head of EMEA
- Jason Leow, Head of APAC
Edelman Smithfield also includes leaders and teams in a total of 25 cities and 15 countries around the world.
In 2015, Edelman acquired Smithfield, a UK-based financial communications firm, as part of its ongoing investment and growth in financial communications. Since that time, the Edelman Smithfield brand has been rolled out in Germany, the Middle East and Canada. Edelman plans to commit significant resources to the continued expansion of the Edelman Smithfield platform in key markets around the world.
About Edelman
Edelman is a global communications firm that partners with businesses and organizations to evolve, promote and protect their brands and reputations. Our 6,000 people in more than 60 offices deliver communications strategies that give our clients the confidence to lead and act with certainty, earning the trust of their stakeholders. Our honors include the Cannes Lions Grand Prix for PR; Advertising Age’s 2019 A-List; the Holmes Report’s 2018 Global Digital Agency of the Year; and, five times, Glassdoor’s Best Places to Work. Since our founding in 1952, we have remained an independent, family-run business. Edelman owns specialty companies Edelman Data x Intelligence (research, data) and United Entertainment Group (entertainment, sports, lifestyle).
About Edelman Smithfield
Edelman Smithfield is a financial communications boutique that specializes in the financial markets and strategic situations with the full reach and resources of Edelman. The Edelman Smithfield team comprises approximately 250 advisors across more than 25 cities and 15 countries serving an expansive roster of top organizations around the world. www.EdelmanSmithfield.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220725005322/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom